Fig. 3

CD146 expression on T cells in lung cancer patients. From the flow cytometry, the expression of the CD 146+ in the T cells includes 4.60 % in healthy patients, 10.10 %, 12.20 %, 9.80 % in adenocarcinoma, squamous and small cell lung cancer respectively